G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 118 filers reported holding G1 THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $595,898 | +2028.2% | 109,339 | +9777.1% | 0.00% | – |
| Q1 2021 | $28,000 | -71.7% | 1,107 | -79.1% | 0.00% | – |
| Q4 2020 | $99,000 | +421.1% | 5,285 | +235.8% | 0.00% | – |
| Q3 2020 | $19,000 | -67.2% | 1,574 | -42.2% | 0.00% | – |
| Q2 2020 | $58,000 | -48.7% | 2,722 | -36.2% | 0.00% | – |
| Q4 2019 | $113,000 | +66.2% | 4,264 | +43.7% | 0.00% | – |
| Q3 2019 | $68,000 | -20.9% | 2,968 | +5.6% | 0.00% | – |
| Q2 2019 | $86,000 | – | 2,811 | +93600.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 3 | -99.1% | 0.00% | – |
| Q4 2018 | $6,000 | -25.0% | 321 | +122.9% | 0.00% | – |
| Q3 2018 | $8,000 | +33.3% | 144 | -0.7% | 0.00% | – |
| Q2 2018 | $6,000 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |